Floatz logo

849 assets in Breast Cancer

Therapeutic assets addressing Breast Cancer, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
(±)-Gossypol Acetic Acid
Breast Cancer
Zhejiang Cancer HospitalP2CCC (53)
HER3 Dendritic Cell Vaccine
Breast Cancer
Roswell Park Cancer InstituteP2CCC (53)
Hyaluronidase Oysk
Breast Cancer
Adrienne G. WaksP2CCC (53)
Hydroxychloroquine
Breast Cancer
University of ArizonaP2CCC (53)
Hyrogen Peroxide
Breast Cancer
Institute of Cancer Research, United KingdomP2CCC (53)
Ivuxolimab
Breast Cancer
Laura Huppert, MD, BAP2CCC (53)
Losartan
Breast Cancer
Massachusetts General HospitalP2CCC (53)
Margetuximab
Breast Cancer
MedSIRP2CCC (53)
Mifepristone
Breast Cancer
Memorial Sloan Kettering Cancer CenterP3CCC (53)
Neratinib Maleate
Breast Cancer
National Cancer Institute (NCI)P2CCC (53)
Nicotine
Breast Cancer
Institut Cancerologie de l'OuestP2CCC (53)
Recombinant Flt3 Ligand
Breast Cancer
University of Southern CaliforniaP1/2CCC (53)
Sotorasib
Breast Cancer
National Cancer Institute (NCI)P2CCC (53)
Starch
Breast Cancer
University of Michigan Rogel Cancer CenterP2CCC (53)
Superparamagnetic Iron Oxide
Breast Cancer
Vastra Gotaland RegionP2CCC (53)
Tagitanlimab
Breast Cancer
West China HospitalP2CCC (53)
Trebananib
Breast Cancer
QuantumLeap Healthcare CollaborativeP2CCC (53)
Tsl-1502 Capsules
Breast Cancer
Jiangsu Tasly Diyi Pharmaceutical Co., Ltd.P2CCC (53)
Vaginal Lactobacillus Capsules
Breast Cancer
The First Affiliated Hospital with Nanjing Medical UniversityP2CCC (53)
Venetoclax
Breast Cancer
Dana-Farber Cancer InstituteP2CCC (53)
Wokvac Vaccine
Breast Cancer
H. Lee Moffitt Cancer Center and Research InstituteP2CCC (53)
(Z)-Endoxifen
Breast Cancer
Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF)P2CCC (53)
Atropine
Breast Cancer
MedSIRP2CCC (52)
Clindamycin
Breast Cancer
Cairo UniversityP3CCC (52)
Clonidine
Breast Cancer
Tufts Medical CenterP2CCC (52)
Duloxetine
Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTCP3CCC (52)
Sonazoid
Breast Cancer
The Netherlands Cancer InstituteP2/3CCC (52)
Sulfur Hexafluoride
Breast Cancer
Milton S. Hershey Medical CenterP3CCC (52)
Vandetanib
Breast Cancer
UNICANCERP2CCC (52)
9mw2821
Breast Cancer
Fudan UniversityP2CCC (51)
Adebelizumab
Breast Cancer
Henan Cancer HospitalP2CCC (51)
ak146d1 for
Breast Cancer
AkesoP2CCC (51)
Alemtuzumab
Breast Cancer
Institut du Cancer de Montpellier - Val d'AurelleP2CCC (51)
Belzutifan
Breast Cancer
Merck Sharp & Dohme LLCP2CCC (51)
coq10
Breast Cancer
Damanhour UniversityP2CCC (51)
hb1801
Breast Cancer
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.P2CCC (51)
Ivarmacitinib
Breast Cancer
Fudan UniversityP2CCC (51)
Mecapegfilgrastim
Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityP2CCC (51)
Meritup
Breast Cancer
Chung Shan Medical UniversityP2CCC (51)
mhb036c for
Breast Cancer
Minghui Pharmaceutical (Hangzhou) LtdP2CCC (51)
mhb039a for
Breast Cancer
Minghui Pharmaceutical (Hangzhou) LtdP2CCC (51)
Omega-N-Methylarginine
Breast Cancer
The Methodist Hospital Research InstituteP2CCC (51)
Pexidartinib
Breast Cancer
Hope Rugo, MDP2CCC (51)
Samfenet
Breast Cancer
Seoul National University HospitalP2CCC (51)
shr2554
Breast Cancer
Henan Cancer HospitalP2CCC (51)
Shr-A1921
Breast Cancer
Fudan UniversityP2CCC (51)
Shr-A2102
Breast Cancer
Fudan UniversityP2CCC (51)
sys6023
Breast Cancer
CSPC Megalith Biopharmaceutical Co.,Ltd.P2CCC (51)
Tiragolumab
Breast Cancer
The Netherlands Cancer InstituteP2CCC (51)
Trastuzumab Deruxtecan For
Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityP2CCC (51)
Showing 301 to 350 of 849 assets
PreviousPage 7 of 17Next